Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target
Abdelwahab, E. M. M., Pal, S., Kvell, K., Sarosi, V., Bai, P., Rue, R., Krymskaya, V., McPhail, D., Porter, A., Pongracz, J. E.
Published in Oncogene (01.04.2019)
Published in Oncogene (01.04.2019)
Get full text
Journal Article
Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility
Rapp, J, Kiss, E, Meggyes, M, Szabo-Meleg, E, Feller, D, Smuk, G, Laszlo, T, Sarosi, V, Molnar, T F, Kvell, K, Pongracz, J E
Published in BMC cancer (23.11.2016)
Published in BMC cancer (23.11.2016)
Get full text
Journal Article
45P Analysis of lung cancer patient pathway: A 6-year nationwide analysis from Hungary
Bogos, K., Gaffly, G., Kiss, Z., Tamási, L., Ostoros, G., Müller, V., Urbán, L., Bittner, N., Sárosi, V., Vastag, A., Polányi, Z., Daniel, A., Nagy, B., Rokszin, G., Abonyi-Tóth, Z., Barcza, Z., Moldvay, J., Vokó, Z.
Published in Journal of thoracic oncology (01.04.2021)
Published in Journal of thoracic oncology (01.04.2021)
Get full text
Journal Article